A synthetic peptide for use as a blocking control in assays to test for specificity of IMPA1 antibody, Alternative Names: IMPA1 control peptide, IMPA1 antibody Blocking Peptide, Anti-IMPA1 Blocking Peptide, Inositol Blocking Peptide, Myo-1 Blocking Peptide, IMPA Blocking Peptide
IMPA1 is responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. IMPA1 can use myo-inositol monophosphates, myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates.